Lenacapavir (LEN) is notable as the first long-acting injectable pre-exposure prophylaxis (PrEP) option requiring only two doses per year.
With its advanced technology and increased capacity, Madagascar is now better equipped to lead efforts against poliovirus transmission across Eastern and Southern Africa.
The campaign aims to vaccinate over 2 million people across the provinces of Cabinda, Kwanza Sul, Huíla, Lunda Norte, Namibe, and Zaire.
This move fulfils one of President Mahama’s key promises to strengthen the connection between the country’s leading teaching hospital and its top university.
GSK’s acquisition of Boston Pharmaceuticals’ BP Asset IX, announced in May 2025, expanded its portfolio to include treatments for liver, lung, and kidney diseases.
The hospital will have 750 beds, create about 5,000 jobs, boost medical tourism, and provide training for medical students, strengthening the local healthcare system.
This achievement assures clients that their wellness journey is backed by trusted medical expertise and best practices.
The new center, spanning nearly 30,000 square feet, is the largest cleft care facility on the African continent.